文献速递慢性肾脏病水电解质与酸碱

白细胞介素-6促进幼年慢性肾脏病贫血的发生

Interleukin-6 Contributes to the Development of Anemia in Juvenile CKD.
PubMed 文献 · Kidney Int Rep · 2018-12-19

该研究在腺嘌呤饮食诱导的幼年野生型与IL-6缺陷小鼠中证实,IL-6缺陷可显著改善CKD小鼠的红细胞计数和血红蛋白,其机制涉及低铁血症、肾纤维化及促红细胞生成素轴。在儿童CKD队列中,校正GFR后仅IL-6与血红蛋白呈显著负相关,且校正CKD分期、铁剂治疗及铁调素后仍显著。

要点

  • IL-6缺陷可改善幼年CKD小鼠贫血,部分通过减轻低铁血症实现。
  • 口服补铁不能完全复制IL-6缺陷的保护作用,提示IL-6有非铁依赖机制。
  • 儿童CKD队列中,校正GFR后仅IL-6与血红蛋白显著负相关。

核心结论

  • IL-6通过诱导低铁血症、加重肾纤维化和改变促红细胞生成素轴促进幼年CKD贫血。

研究设计与样本

  • 研究用腺嘌呤饮食在幼年野生型和IL-6缺陷小鼠中诱导CKD,并检测儿童CKD患者血清IL-6及相关指标。

主要发现

  • 野生型CKD小鼠出现贫血,尽管血清促红细胞生成素升高,但血清铁降低、血清IL-6升高。
  • IL-6缺陷显著改善CKD小鼠的红细胞计数和血红蛋白,并改善低铁血症,可能由铁调素介导。
  • 在儿童CKD队列的10种细胞因子中,校正GFR后仅IL-6与血红蛋白呈显著负相关。
  • 儿童CKD中IL-6与血红蛋白的关联在校正CKD分期、铁剂治疗和铁调素后仍显著。

临床怎么用

  • IL-6可能作为儿童CKD贫血管理的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Anemia is a common complication of chronic kidney disease (CKD) in children; however, the role of inflammation in its pathogenesis remains incompletely understood. METHODS: To elucidate the role of interleukin (IL)-6 in renal anemia, we induced CKD by adenine diet in juvenile wild-type (WT) and IL-6 deficient (Il6KO) mice, and examined serum IL-6 and relevant parameters in children with CKD. RESULTS: WT-CKD mice developed anemia despite increases in serum erythropoietin and displayed low serum iron and elevated serum IL-6. IL-6 deficiency resulted in a significant improvement of red blood cell count and hemoglobin in CKD mice. This effect was associated with improvement of hypoferremia by Il6 deletion, likely mediated by hepcidin. However, correction of hypoferremia by oral iron supplementation in WT-CKD mice did not fully replicate the protective effects of Il6 deletion, suggesting an additional iron-independent role for IL-6 in CKD-anemia. Indeed, Il6 deletion mitigated the severity of renal fibrosis and alleviated relative erythropoietin insufficiency in CKD mice. Cytokine profiling in a pediatric CKD cohort demonstrated that of 10 cytokines (IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13, tumor necrosis factor (TNF)-α, and interferon-γ), only IL-6 was significantly (inversely) associated with hemoglobin when adjusted for glomerular filtration rate (GFR). The association between IL-6 and hemoglobin in children with CKD remained significant after adjustment for CKD stage, iron therapy, and hepcidin. DISCUSSION: IL-6 contributes to development of anemia in juvenile CKD, through mechanisms that include induction of hypoferremia, aggravation of renal fibrosis, and alteration of the erythropoietin axis. IL-6 appears to be a promising therapeutic target in the management of CKD-anemia.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Akchurin O, Patino E, Dalal V, et al. Interleukin-6 Contributes to the Development of Anemia in Juvenile CKD. Kidney Int Rep. 2018. PMID: 30899874. doi:10.1016/j.ekir.2018.12.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。